Study advances PCR detection of Campylobacter jejuni in dogs

A newly published study in the Journal of Veterinary Diagnostic Investigation focuses on inter-laboratory optimization of gyrA PCR for detecting Campylobacter jejuni in canine fecal samples, a niche diagnostic question with broader implications for zoonotic surveillance. The work lands in a field that’s been shaped by the 2016–2018 U.S. multidrug-resistant C. jejuni outbreak linked to puppy exposure, which underscored that dogs can be a source of human infection and that better canine testing tools are needed. (cdc.gov)

That background matters. In a related 2026 paper from many of the same investigators, direct real-time PCR targeting cpn60 on DNA extracted straight from canine feces was more sensitive than culture and more accurate than PCR performed after enrichment broth, with a five-laboratory limit of detection of 320 cfu/g. The authors also noted that C. jejuni testing isn’t routinely performed in dogs, even though dogs may shed the organism without obvious illness and prior studies have found canine carriage in shelters, clinics, and community settings. (journals.sagepub.com)

The new gyrA study appears to be the next step in that optimization pathway. USDA National Agricultural Library project materials describe a Vet-LIRN-backed effort led by Texas A&M collaborators to validate molecular methods targeting gyrA in canine feces and test them in five independent, blinded laboratories. Those materials say the project was motivated by Ohio Vet-LIRN findings suggesting gyrA primers offered improved detection in canine feces, and by the lack of standardized methods that make cross-laboratory comparisons difficult. (nal.usda.gov)

The earlier inter-laboratory work helps explain why that matters operationally. In the cpn60 validation study, a 2017 comparison exercise across 28 laboratories saw sensitivity collapse to 24.6% when 79% of shipped packages warmed to at least 5°C in transit. After the team increased sample volume, improved insulation, added more detailed extraction instructions, and used temperature loggers, a follow-up shipping exercise across five laboratories reached 97.9% sensitivity and 98.0% specificity. In other words, assay reproducibility depended not just on target selection, but on specimen stability and standardized handling from collection through extraction. (journals.sagepub.com)

Industry-facing implications are already visible. Texas A&M’s Veterinary Medical Diagnostic Laboratory currently lists a Campylobacter jejuni real-time PCR test for canine feces, among other specimen types, and emphasizes fresh samples and cold-chain shipping. That suggests at least some diagnostic infrastructure is already in place for molecular detection, even as broader standardization continues. The same research group has also argued that PCR-positive samples should still be followed by culture, susceptibility testing, and whole-genome sequencing when isolates can be recovered, especially for outbreak monitoring and antimicrobial resistance tracking. (tvmdl.tamu.edu)

Why it matters: For veterinary professionals, the practical takeaway is that improved molecular detection of C. jejuni could strengthen both case workups and public health response. Dogs with diarrhea, shelter or kennel populations, and puppies with links to retail distribution chains can all sit at the animal-human interface. Better-performing, more reproducible PCR could help labs identify cases faster than culture alone, while still reserving culture for isolate recovery and susceptibility work. That’s particularly relevant because the CDC’s 2016–2018 outbreak investigation tied 106 reported infections to puppy exposure, most involving pet store puppies, and highlighted heavy antibiotic exposure among affected puppies. (cdc.gov)

There’s also a stewardship angle. The outbreak literature and follow-on reporting have kept attention on commercially distributed puppies as a potential reservoir for drug-resistant Campylobacter, while Cornell researchers have described multidrug-resistant C. jejuni in dogs as potentially underdiagnosed. For clinics and diagnostic labs, that raises the value of tests that are sensitive enough for surveillance, but standardized enough to support comparisons across laboratories and over time. (pmc.ncbi.nlm.nih.gov)

What to watch: The next key question is whether the published gyrA paper demonstrates a clear performance advantage over prior cpn60 methods and whether that translates into broader adoption by veterinary diagnostic laboratories, Vet-LIRN protocols, or outbreak-response guidance. (nal.usda.gov)